Silvi Shah,Janani Rangaswami
Silvi Shah
History and Evolution of Hypertension Goals in Patients with Chronic Kidney Disease [0.03%]
慢性肾脏病高血压患者的治疗目标的历史和发展变迁
Blaise W Abramovitz,Alavi Hossain,Rushelle Byfield et al.
Blaise W Abramovitz et al.
Optimal blood pressure targets for patients with chronic kidney disease (CKD) remain a subject of ongoing debate. This review explores the evolution of evidence guiding blood pressure treatment thresholds in patients with CKD, highlighting ...
Emma Heydari Ulrich,Daphney Kernizan,Rahul Chanchlani et al.
Emma Heydari Ulrich et al.
Cardio-kidney metabolic (CKM) syndrome refers to the interconnected dysfunction of the cardiovascular, renal, and metabolic systems, leading to an increased risk of chronic conditions like hypertension, diabetes, and heart disease. In pedia...
A Plant-Based Diet for Cardiovascular Risk Reduction in Kidney Disease with a Focus on Cardiovascular-Kidney-Metabolic Syndrome [0.03%]
针对心血管-肾脏-代谢综合征的肾病人群行之有效的植物性饮食以降低心血管风险
Rachel Shi,Mario Mendoza-Sanchez,Maryam Qadir et al.
Rachel Shi et al.
Cardiovascular-kidney-metabolic (CKM) syndrome is a complex disorder involving an interplay of metabolic risk factors such as obesity, type 2 diabetes mellitus, hyperlipidemia, hypertension, and chronic kidney disease. Because these risk fa...
Long-Term Cardio-Renal-Metabolic Complications Following Pre-eclampsia [0.03%]
妊娠期高血压疾病的 cardio-renal-metabolic 远期并发症
Bianca Davidson,Brain Rayner,Nicola Wearne et al.
Bianca Davidson et al.
Hypertensive disorders of pregnancy affect approximately 10% of all pregnancies where the prevalence is expected to rise. Post pregnancy, there are long-term health risks to mother and child. Mothers who experience hypertensive disorders du...
Arksarapuk Jittirat,Swee-Ling Levea,Beatrice P Concepcion et al.
Arksarapuk Jittirat et al.
Kidney transplantation (KT) is the treatment of choice for suitable candidates with advanced kidney disease, offering improved survival compared with chronic dialysis. However, KT recipients remain at high risk for cardiovascular mortality ...
Atherosclerotic Cardiovascular Disease in Cardiovascular-Kidney-Metabolic Syndrome [0.03%]
心血管-肾脏-代谢综合征的动脉粥样硬化性心血管病
Alyssa M Sanchez,Nikitha M Murthy,Anastasia Shakhbazova et al.
Alyssa M Sanchez et al.
Atherosclerotic cardiovascular disease (CVD) remains an important cause of morbidity and mortality globally. The novel American Heart Association cardiovascular kidney metabolic health framework highlights a graded accumulation of these ris...
Role of Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in Management of Cardiovascular-Kidney-Metabolic (CKM) Conditions [0.03%]
胰高血糖素样肽-1和葡萄糖依赖性促胰岛素多肽/胰高血糖素样肽-1受体激动剂在心血管-肾脏-代谢(CKM)疾病管理中的作用
Radica Z Alicic,Joshua J Neumiller
Radica Z Alicic
Use of glucagon-like peptide-1 (GLP-1) and dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonists, initially developed as glucose-lowering therapies for the management of type 2 diabetes, continues to expand in para...
Sodium Glucose Cotransporter 2 Inhibitors Across the Spectrum of Cardiovascular Kidney Metabolic Syndrome [0.03%]
钠-葡萄糖共转运蛋白2抑制剂在心血管肾脏代谢综合征谱系中的应用
Kevin Bryan Lo,Karim Iskarous,Rajiv Sankaranarayanan
Kevin Bryan Lo
The burden of metabolic diseases including diabetes and obesity is rising. Excess and dysfunctional adipose tissue can lead to inflammation and contribute to insulin resistance. Eventually, downstream effects include both cardiac and kidney...
Obesity and Cardiovascular-Kidney-Metabolic Health: Ethnicity-Based Risk and Clinical Considerations [0.03%]
肥胖与心血管-肾脏-代谢健康：基于种族的风险和临床考量
Sai Nikhila Ghanta,Candace Lessey,Bhargav Makwana et al.
Sai Nikhila Ghanta et al.
The global prevalence of obesity has tripled since 1990, adversely affecting the cardiovascular, kidney, and metabolic health of individuals worldwide. Studies show that obesity varies across ethnic groups, with Black and Hispanic adults ha...